Bob Langer, ChemE '70, co-founder of Moderna Therapeutics, a company that develops treatments that leverage specialized transporter molecules in cells known as messenger RNAs

Bob Langer, ChemE '70, co-founder of Moderna Therapeutics, a company that develops treatments that leverage specialized transporter molecules in cells known as messenger RNAs. Messenger RNAs bring instructions from genes to the cellular machinery that makes proteins. By creating specially modified mRNA, Moderna believes it can develop therapies to treat and prevent a number of diseases in humans.

http://news.mit.edu/2020/mit-companies-covid-19-0326

Other Articles of Interest